Jazz Pharmaceuticals (JAZZ) was upgraded to a 'Buy' recommendation by TheStreet.com's quantitative service today. Let's check out the price charts and technical indicators to see if they are in agreement.
More from Investing
While known for a couple of big crashes, October is often a transitional month for the market.
Neither candidate seems to be the enemy of the market -- at least not yet.
I believe we are in a transition period, and here's what to look for in the next few employment reports.
If you bought NIO in July or earlier you have hit a home run.